Ben-Noon Alon bought NRSN
June 16, 2026 · Form 4 insider transaction
Ben-Noon Alon bought 250,000 shares of NeuroSense Therapeutics Ltd. at $0.80 per share, a transaction worth $200.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
250,000
Price
$0.80
Total value
$200.0K
InsiderBen-Noon Alon
Role—
SecurityOrdinary Shares
Transaction codeP: Open-market purchase
Transaction dateJune 16, 2026
Filing dateJune 17, 2026
Shares owned after4,534,233
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
On June 16, 2026, the Reporting Person acquired 250,000 ordinary shares, no par value per share, of the Issuer at a purchase price of $0.80 per share, pursuant to a Securities Purchase Agreement dated April 28, 2026, in a private placement exempt from registration under Section 4(a)(2) of the Securities Act of 1933, as amended.